Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: Aging effect on diagnostic performance

Journal of Nuclear Medicine

Volumn 48, Issue 12, 2007, Pages 1961-1970

  Matsunari, Ichiro ^a   Samuraki, Miharu ^b   Chen, Wei Ping ^a   Yanase, Daiseke ^b   Takeda, Nozomi ^a   Ono, Kenjiro ^b   Yoshita, Mitsuhiro ^b   Matsuda, Hiroshi ^c   Yamada, Masahito ^b   Kinuya, Seigo ^b  

^a Medical and Pharmacological Research Center Foundation   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

18F FDG PET; Alzheimer's disease; Voxel based morphometry

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; CINGULATE GYRUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DRUG UPTAKE; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; TEMPORAL LOBE; AGE; COMPARATIVE STUDY; DIAGNOSTIC ERROR; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTISCANNING;

AGE FACTORS; AGED; ALZHEIMER DISEASE; DIAGNOSTIC ERRORS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 36849092315     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.042820     Document Type: Article

References (29)

1. Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology. 2003;226:315-336.
2. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 1995;2:189-210.
3. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238-1248.
4. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42:85-94.
5. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001;286:2120-2127.
6. Herholz K. PET studies in dementia. Ann Nucl Med. 2003;17:79-89.
7. De Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging. 1997;18:1-11.
8. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52:1397-1403.
9. Grundman M, Sencakova D, Jack CR Jr, et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci. 2002;19:23-27.
10. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage. 2000;11:805-821.
11. Good CD, Scahill RI, Fox NC, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage. 2002;17:29-46.
12. Hirata Y, Matsuda H, Nemoto K, et al. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett. 2005;382:269-274.
13. Bookstein FL. "Voxel-based morphometry" should not be used with imperfectly registered images. Neuroimage. 2001;14:1454-1462.
14. Kawachi T, Ishii K, Sakamoto S, et al. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2006;33:803-809.
15. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14:21-36.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
17. Yanase D, Matsunari I, Yajima K, et al. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol Imaging. 2005;32:794-805.
18. Nowinski WL, Fang A, Nguyen BT, et al. Multiple brain atlas database and atlas-based neuroimaging system. Comput Aided Surg. 1997;2:42-66.
19. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage. 2001;14:685-700.
20. Nichols T, Hayasaka S. Controlling the familywise error rate in functional neuroimaging: a comparative review. Stat Methods Med Res. 2003;12:419-446.
21. Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med. 2007;48:1289-1300.
22. Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristic rating analysis: generalization to the population of readers and patients with the jackknife method. Invest Radiol. 1992;27:723-731.
23. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17:302-316.
24. Ishii K, Sasaki H, Kono AK, Miyamoto N, Fukuda T, Mori E. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDGPET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging. 2005;32:959-963.
25. Mosconi L, Sorbi S, de Leon MJ, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med. 2006;47:1778-1786.
26. Sakamoto S, Ishii K, Sasaki M, et al. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J Neurol Sci. 2002;200:27-32.
27. Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry. 2005;76:112-114.
28. Frisoni GB, Pievani M, Testa C, et al. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain. 2007;130:720-730.
29. Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord. 1996;10:180-188.